PARTNERSHIP FOR ACCELERATING CANCER THERAPIES Trademark

Trademark Overview

On Thursday, August 31, 2017, a trademark application was filed for PARTNERSHIP FOR ACCELERATING CANCER THERAPIES with the United States Patent and Trademark Office. The USPTO has given the PARTNERSHIP FOR ACCELERATING CANCER THERAPIES trademark a serial number of 87979166. The federal status of this trademark filing is SECTION 8 - ACCEPTED as of Monday, November 17, 2025. This trademark is owned by U.S. Department of Health and Human Services. The PARTNERSHIP FOR ACCELERATING CANCER THERAPIES trademark is filed in the Advertising, Business and Retail Services and Insurance & Financial Services categories with the following description:

Business management and business development services, namely, management of research grants, business program management, and promoting collaboration within the scientific, research, academic, and provider communities to achieve advances in the field of human health; Promotion of biomedical research programs of others

Providing grants and financial support to researchers, companies, and health care providers for biomedical research
partnership for accelerating cancer therapies

General Information

Serial Number87979166
Word MarkPARTNERSHIP FOR ACCELERATING CANCER THERAPIES
Filing DateThursday, August 31, 2017
Status701 - SECTION 8 - ACCEPTED
Status DateMonday, November 17, 2025
Registration Number5658275
Registration DateTuesday, January 15, 2019
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesBusiness management and business development services, namely, management of research grants, business program management, and promoting collaboration within the scientific, research, academic, and provider communities to achieve advances in the field of human health; Promotion of biomedical research programs of others
Goods and ServicesProviding grants and financial support to researchers, companies, and health care providers for biomedical research

Classification Information

International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateFriday, September 8, 2017
Primary Code035
First Use Anywhere DateThursday, October 12, 2017
First Use In Commerce DateThursday, October 12, 2017
International Class036 - Insurance; financial affairs; monetary affairs; real estate affairs.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateFriday, September 8, 2017
Primary Code036
First Use Anywhere DateThursday, October 12, 2017
First Use In Commerce DateThursday, October 12, 2017

Trademark Owner History

Party NameU.S. Department of Health and Human Services
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressBethesda, MD 20892-2111
Party NameU.S. Department of Health and Human Services
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBethesda, MD 208922111

Trademark Events

Event DateEvent Description
Monday, September 4, 2017NEW APPLICATION ENTERED
Friday, September 8, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, September 28, 2017ASSIGNED TO EXAMINER
Tuesday, October 10, 2017NON-FINAL ACTION WRITTEN
Tuesday, October 10, 2017NON-FINAL ACTION E-MAILED
Tuesday, October 10, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, April 3, 2018TEAS AMENDMENT OF USE RECEIVED
Wednesday, April 4, 2018USE AMENDMENT FILED
Wednesday, April 4, 2018AMENDMENT TO USE PROCESSING COMPLETE
Wednesday, April 4, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, April 16, 2018ASSIGNED TO LIE
Tuesday, April 17, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, April 17, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Sunday, April 22, 2018USE AMENDMENT ACCEPTED
Tuesday, April 24, 2018NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
Tuesday, May 15, 2018NON-FINAL ACTION WRITTEN
Tuesday, May 15, 2018NON-FINAL ACTION E-MAILED
Tuesday, May 15, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, November 8, 2018TEAS REQUEST TO DIVIDE RECEIVED
Friday, November 9, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, November 13, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, November 13, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, November 21, 2018CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, November 8, 2018DIVISIONAL REQUEST RECEIVED
Monday, November 26, 2018DIVISIONAL PROCESSING COMPLETE
Tuesday, December 4, 2018APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
Tuesday, December 11, 2018LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, January 15, 2019REGISTERED-SUPPLEMENTAL REGISTER
Monday, January 4, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, January 4, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, January 4, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, January 4, 2021TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Monday, January 4, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, January 4, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, January 15, 2024COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, July 15, 2025TEAS SECTION 8 RECEIVED
Monday, November 17, 2025CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, November 17, 2025REGISTERED - SEC. 8 (6-YR) ACCEPTED
Monday, November 17, 2025NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED

Related Keywords

therapies cancer accelerating partnership research business management health biomedical grants others programs promotion providing